About
Editorial methods
StackItSmart is an educational compound reference. Its purpose is to make inspected evidence and unresolved questions easier to read together.
From source to statement
The evidence cutoff for this edition is September 8, 2026. Each source records its actual access date separately. A source title, a matching PMID or a previous verification flag is not sufficient support for a clinical claim.
Published findings link to an inspected passage, label section, table or abstract result. Records specify the study design, population and limitations; formulation and route are stated where relevant. Abstract-only inspection is labeled explicitly. It does not stand in for reading the full paper.
Corrections, retractions and conflicting findings are recorded where checked. These checks have a defined scope and can miss later updates or unindexed material. This is not an exhaustive systematic review of every compound.
Evidence and review status
| Evidence type | What supports this particular finding? A regulator record, human randomized or observational study, review, case report, preclinical result or mechanistic inference. |
|---|---|
| Source verification | What was inspected? A supporting passage, label or regulator record, or an abstract only. Verification describes the editorial action, not the certainty of the science. |
| Clinical review | Has an identified qualified clinician reviewed this finding? No qualified clinical reviewer is claimed for this edition. |
Approval has a specific scope
Regulatory records identify the jurisdiction, product, indication and date. Approval of a licensed product is not approval of every formulation or every proposed use of the molecule. Trial populations and research-market products are not interchangeable.
The SS-31 / Forzinity record illustrates why that distinction matters.
Unresolved evidence
Compound records and their established URLs remain available when evidence is unresolved. Uninspected claims, unsupported organ-risk ratings, fixed recovery timelines and simulated drug curves are excluded from the published findings. Each record identifies the unresolved topics and verification attempts.
This edition contains 128 compound records, 308 findings and 270 inspected source records; 121 source records were inspected as abstracts only. These counts describe the work recorded here. They do not establish completeness or certainty.
How the checker should be read
The interaction checker separates directly documented evidence, class extrapolation and theoretical concern. A case describing two substances together does not by itself prove an interaction caused the outcome. Alert severity is distinct from evidence strength.
Pair combinations generated by the software are not counts of studied combinations. No curated interaction evidence means that safety is unknown. The checker does not recommend combinations, assess personal suitability or suggest alternatives.
Editorial boundaries
For adults 21 and older. Educational information only, not medical advice. The site does not provide sourcing, cycle builders, performance optimization, dosing recommendations or recovery regimens. Personal health questions belong with qualified healthcare professionals.
For an editorial correction, include the page, the specific statement and the supporting source when contacting eligorelick01@gmail.com. This is an editorial contact, not a clinical service.